Table 1.
Literature review of cardiac calcified amorphous tumour cases (n=63)
| Variables | Values |
| Age | 58±17 (16–85) |
| Male:Female | 24:39 |
| Tumour site | |
| Left heart | 45 (71) |
| MV (multiple possible) | 30 (48) |
| LV (multiple possible) | 16 (25) |
| LA | 5 (8) |
| PM (multiple possible) | 1 (2) |
| Right heart | 18 (29) |
| RV (multiple possible) | 8 (14) |
| TV (multiple possible) | 2 (3) |
| RA (multiple possible) | 9 (14) |
| SVC (multiple possible) | 1 (2) |
| Comorbidities | |
| ESRD | 23 (37) |
| HD | 21 (23) |
| Non-HD | 1 (2) |
| Peritoneal dialysis | 1 (2) |
| MAC | 19 (32) |
| DM | 15 (24) |
| Embolism | 21 (33) |
| Arterial system | 15 (24) |
| CI | 9 (14) |
| TIA | 1 (2) |
| Retinal artery | 3 (5) |
| ALI | 1 (2) |
| MI | 1 (2) |
| Venous circulation | 6 (10) |
| PE | 6 (10) |
| Treatment | |
| Surgical excision | 56 (89) |
| Aspirin | 1 (2) |
Values are given as mean±SD, no. (%) or <range>.
ALI, acute limb ischaemia; CI, cerebellar infarction; ESRD, end-stage renal disease; HD, haemodialysis; LA, left atrial; LV, left ventricular; MAC, mitral annular calcification; MI, myocardial infarction; MV, mitral valve; PE, pulmonary embolism; PM, papillary muscle; RA, right atrial; RV, right ventricular; SVC, superior vena cava; TIA, transient ischaemic attack; TV, tricuspid valve.